Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» generics
generics
Novartis strikes marketing deal for Polpharma’s potential Tysabri biosimilar
Pharmaforum
Tue, 09/3/19 - 10:30 am
Novartis
Sandoz
generics
biosimilars
Tysabri
Polpharma
Mylan's Lantus copy derailed in U.S. again by manufacturing ills
Fierce Pharma
Tue, 09/3/19 - 10:24 am
Mylan
Lantus
generics
Biocon
drug manufacturing
diabetes
Mylan's Newly-Approved Alimta Generic Will Not be Sold Until 2022
BioSpace
Mon, 09/2/19 - 12:25 pm
Eli Lilly
Mylan
Alimta
FDA
generics
lung cancer
Mylan up on OK for generic of Lilly’s $2bn cancer drug Alimta
Pharmaforum
Fri, 08/30/19 - 10:48 am
Mylan
Eli Lilly
generics
Alimta
non-squamous non-small cell lung cancer
mesothelioma
Analysis Shows Eli Lilly’s Half-Price Humalog Generic Is Not Readily Available Across the U.S.
BioSpace
Thu, 08/29/19 - 08:16 pm
diabetes
insulin
Humalog
generics
Eli Lilly
Lispro
Novo Nordisk and Mylan Battle Over Generic Versions of Victoza
BioSpace
Thu, 08/22/19 - 05:01 pm
Novo Nordisk
Mylan
generics
Victoza
diabetes
Lyrica looking grim: Pfizer blockbuster's market share crumbles under generic attack
Fierce Pharma
Mon, 08/19/19 - 11:46 pm
Pfizer
patents
Lyrica
generics
Generic Drug Approvals Hit Another Record High as Competition, Quality Questions Linger
RAPS.org
Fri, 08/16/19 - 11:52 pm
generics
FDA
Sanofi defends top oncology drug with Jevtana patent win
Fierce Pharma
Thu, 08/15/19 - 12:21 pm
Sanofi
patents
generics
Jevtana
oncology
3 generic drugmakers accused of 'stonewalling' congressional probe
Beckers Hospital Review
Thu, 08/15/19 - 10:41 am
generics
Mylan
Teva Pharmaceutical
Heritage Pharmaceuticals
Dr. Reddy's Copaxone, NuvaRing generics derailed by FDA
Fierce Pharma
Thu, 08/15/19 - 10:39 am
FDA
Dr Reddy's
Copaxone
Teva Pharmaceutical
generics
Merck
Nuvaring
What Enbrel needs to do after its patent win
EP Vantage
Mon, 08/12/19 - 11:48 am
Amgen
Enbrel
patents
generics
Enbrel ruling lifts Amgen shares
BioCentury
Sat, 08/10/19 - 02:02 pm
Amgen
Enbrel
patents
Sandoz
generics
GAO Pushes FDA to Improve First Cycle Generic Approval Rate
RAPS.org
Fri, 08/9/19 - 07:41 pm
GAO
drug approvals
FDA
generics
Under a cloud of opioid lawsuits, Mallinckrodt suspends specialty generics spinoff
Endpoints
Tue, 08/6/19 - 01:05 pm
Mallinckrodt
opioids
generics
Sonorant Therapeutics
SpecGx
Drugmakers master rolling out their own generics to stifle competition
Fierce Pharma
Mon, 08/5/19 - 10:39 am
generics
PDL Biopharma
Tekturna
Hatch Waxman Act
Lyrica Patent Expiration Ushers In 9 Generic Competitors
Xtalks
Thu, 07/25/19 - 07:06 pm
Pfizer
Lyrica
patents
generics
Alembic Pharmaceuticals
Alkem Laboratories
Amneal
Dr Reddy's
InvaGen
MGN Laboratories
Rising Pharmaceuticals
Sciegen Pharmaceuticals
Teva Pharmaceutical
Opioid and price fixing legal liabilities mount for generic companies
Biopharma Dive
Mon, 07/22/19 - 08:08 pm
generics
opioids
price fixing
Purdue Pharma
Mylan
Endo
Amneal
Teva Pharmaceutical
Novartis’ sunny Sandoz forecast is at odds with the reality of the US generics market: analysts
Fierce Pharma
Fri, 07/19/19 - 10:47 am
Novartis
generics
Sandoz
J&J warns generics will bite its pharma unit in the second half
Pharmaforum
Wed, 07/17/19 - 09:49 am
JNJ
generics
biosimilars
Darzalex
Zytiga
Pages
« first
‹ previous
…
10
11
12
13
14
15
16
17
18
…
next ›
last »